患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Recruiting

• Longitudinal Studies of Brain Structure and Function in MPS Disorders
• Mucopolysaccharidosis Type I;Mucopolysaccharidosis Type II;Mucopolysaccharidosis Type VI;Mucopolysaccharidosis Type IV;Mucopolysaccharidosis Type VII
• Canada, United States
• 2011-08-02

• Recruiting

• Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
• Hodgkin Disease;Lymphoma;Lymphoma, Non-Hodgkin;Immune System Diseases;Immunoproliferative Disorders;Lymphatic Diseases;Lymphoproliferative Disorders;Neoplasms;Neoplasms by Histologic Type
• United States
• 2016-01-17

• Recruiting

• Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome
• Metastatic Myxoid Liposarcoma;Metastatic Round Cell Liposarcoma;Metastatic Synovial Sarcoma;NY-ESO-1 Positive Tumor Cells Present;Recurrent Mycosis Fungoides and Sezary Syndrome;Refractory Mycosis Fungoides and Sezary Syndrome;Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7;Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7;Unresectable Synovial Sarcoma
• United States
• 2017-02-22

• Recruiting

• Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
• Ewing Sarcoma;Rhabdomyosarcoma;Wilms Tumor;Osteosarcoma;Non-Rhabdomyosarcoma Soft Tissue Sarcoma, Nos;Renal Tumor;Rhabdoid Tumor;Clear Cell Renal Cell Carcinoma;Sarcoma;Sarcoma, Ewing;Soft Tissue Sarcoma
• United States
• 2015-10-19

• Recruiting

• Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
• High Risk Pregnancy;Congenital Heart Disease;Fetal Hydrops;Twin Monochorionic Monoamniotic Placenta;Gastroschisis;Fetal Demise;Stillbirth;Fetal Arrhythmia;Long QT Syndrome;Intrauterine Fetal Death;Sudden Infant Death;Pregnancy Loss;Twin Twin Transfusion Syndrome;Birth Defect;Fetal Cardiac Anomaly;Fetal Cardiac Disorder;Fetal Death;Brugada Syndrome
• United States
• 2018-10-24

• Recruiting

• EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
• Pediatric Solid Tumor;Germ Cell Tumor;Retinoblastoma;Hepatoblastoma;Wilms Tumor;Rhabdoid Tumor;Carcinoma;Osteosarcoma;Ewing Sarcoma;Rhabdomyosarcoma;Synovial Sarcoma;Clear Cell Sarcoma;Malignant Peripheral Nerve Sheath Tumors;Desmoplastic Small Round Cell Tumor;Soft Tissue Sarcoma;Neuroblastoma
• United States
• 2018-07-16

• Recruiting

• AR-Power Patient Powered Research Network
• Rheumatoid Arthritis;Ankylosing Spondylitis;Fibromyalgia;Gout;Crohn Disease;Juvenile Idiopathic Arthritis;Lupus Erythematosus;Myositis;Osteoarthritis;Osteoporosis;Psoriasis;Psoriatic Arthritis;Scleroderma
• United States
• 2019-02-12

• Recruiting

• CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Patients With Recurrent or Refractory CD19 Positive Diffuse Large B-Cell Lymphoma or B Acute Lymphoblastic Leukemia
• B Acute Lymphoblastic Leukemia;CD19 Positive;Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation;Diffuse Large B-Cell Lymphoma, Not Otherwise Specified;Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly;Minimal Residual Disease;Philadelphia Chromosome Positive;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma;T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
• United States
• 2017-07-26

• Recruiting

• Mayo AVC Registry and Biobank
• Arrhythmogenic Right Ventricular Cardiomyopathy;Cardiomyopathies;Heart Diseases;Cardiovascular Diseases;Sudden Cardiac Arrest;Sudden Cardiac Death;Arrhythmogenic Right Ventricular Dysplasia;Arrhythmogenic Ventricular Cardiomyopathy;Familial Dilated Cardiomyopathy;Cardiovascular Abnormalities;Sarcoidosis;Cardiac Arrhythmia;Cardiac Sarcoidosis;Myocarditis;Inflammatory Cardiomyopathy;Ventricular Tachycardia;Right Ventricular Outflow Tract Ventricular Tachycardia;Arrhythmogenic Right Ventricular Cardiomyopathy;Cardiomyopathies;Heart Diseases;Cardiovascular Diseases;Sudden Cardiac Arrest;Sudden Cardiac Death;Arrhythmogenic Right Ventricular Dysplasia;Arrhythmogenic Ventricular Cardiomyopathy;Familial Dilated Cardiomyopathy;Cardiovascular Abnormalities;Sarcoidosis;Cardiac Arrhythmia;Cardiac Sarcoidosis;Myocarditis;Inflammatory Cardiomyopathy;Ventricular Tachycardia;Right Ventricular Outflow Tract Ventricular Tachycardia
• United Kingdom, United States
• 2017-01-30

• Recruiting

• CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
• CCM;Cavernoma;Cerebral Cavernous Malformation;Cerebral Cavernous Malformations 1;Cerebral Cavernous Malformations 2;Cerebral Cavernous Malformations 3;Cavernous Angioma;CCM;Cavernoma;Cerebral Cavernous Malformation;Cerebral Cavernous Malformations 1;Cerebral Cavernous Malformations 2;Cerebral Cavernous Malformations 3;Cavernous Angioma
• United States
• 2018-07-18

• Recruiting

• Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
• Accelerated Phase Chronic Myelogenous Leukemia;Adult Acute Lymphoblastic Leukemia in Remission;Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;Adult Acute Myeloid Leukemia With Del(5q);Adult Nasal Type Extranodal NK/T-cell Lymphoma;Anaplastic Large Cell Lymphoma;Angioimmunoblastic T-cell Lymphoma;Blastic Phase Chronic Myelogenous Leukemia;Childhood Acute Lymphoblastic Leukemia in Remission;Childhood Burkitt Lymphoma;Childhood Chronic Myelogenous Leukemia;Childhood Diffuse Large Cell Lymphoma;Childhood Immunoblastic Large Cell Lymphoma;Childhood Myelodysplastic Syndromes;Childhood Nasal Type Extranodal NK/T-cell Lymphoma;Chronic Myelomonocytic Leukemia;Chronic Phase Chronic Myelogenous Leukemia;Cutaneous B-cell Non-Hodgkin Lymphoma;de Novo Myelodysplastic Syndromes;Essential Thrombocythemia;Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Hepatosplenic T-cell Lymphoma;Intraocular Lymphoma;Juvenile Myelomonocytic Leukemia;Nodal Marginal Zone B-cell Lymphoma;Noncutaneous Extranodal Lymphoma;Peripheral T-cell Lymphoma;Polycythemia Vera;Post-transplant Lymphoproliferative Disorder;Previously Treated Myelodysplastic Syndromes;Primary Myelofibrosis;Recurrent Adult Acute Myeloid Leukemia;Recurrent Adult Burkitt Lymphoma;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Adult Diffuse Mixed Cell Lymphoma;Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;Recurrent Adult Grade III Lymphomatoid Granulomatosis;Recurrent Adult Hodgkin Lymphoma;Recurrent Adult Immunoblastic Large Cell Lymphoma;Recurrent Adult Lymphoblastic Lymphoma;Recurrent Adult T-cell Leukemia/Lymphoma;Recurrent Childhood Acute Myeloid Leukemia;Recurrent Childhood Anaplastic Large Cell Lymphoma;Recurrent Childhood Grade III Lymphomatoid Granulomatosis;Recurrent Childhood Large Cell Lymphoma;Recurrent Childhood Lymphoblastic Lymphoma;Recurrent Childhood Small Noncleaved Cell Lymphoma;Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Mycosis Fungoides/Sezary Syndrome;Recurrent Small Lymphocytic Lymphoma;Recurrent/Refractory Childhood Hodgkin Lymphoma;Refractory Anemia With Excess Blasts;Refractory Anemia With Excess Blasts in Transformation;Refractory Cytopenia With Multilineage Dysplasia;Refractory Hairy Cell Leukemia;Refractory Multiple Myeloma;Relapsing Chronic Myelogenous Leukemia;Secondary Acute Myeloid Leukemia;Small Intestine Lymphoma;Splenic Marginal Zone Lymphoma;T-cell Large Granular Lymphocyte Leukemia;Testicular Lymphoma;Waldenström Macroglobulinemia
• United States
• 2013-01-02

• Recruiting

• Project: Every Child for Younger Patients With Cancer
• Central Nervous System Neoplasm;Childhood Immature Teratoma;Childhood Langerhans Cell Histiocytosis;Childhood Malignant Neoplasm;Childhood Mature Teratoma;Congenital Mesoblastic Nephroma;Desmoid-Type Fibromatosis;Lymphoproliferative Disorder;Myeloproliferative Neoplasm;Stromal Neoplasm
• Australia, Canada, New Zealand, Puerto Rico, Saudi Arabia, United States
• 2015-03-25

• Recruiting

• Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
• Constitutional Mismatch Repair Deficiency Syndrome;Lynch Syndrome;Malignant Glioma;Progressive Ependymoma;Progressive Medulloblastoma;Recurrent Brain Neoplasm;Recurrent Childhood Ependymoma;Recurrent Diffuse Intrinsic Pontine Glioma;Recurrent Medulloblastoma;Refractory Brain Neoplasm;Refractory Diffuse Intrinsic Pontine Glioma;Refractory Ependymoma;Refractory Medulloblastoma
• United States
• 2015-02-09

• Recruiting

• Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
• Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3a Follicular Lymphoma;Recurrent Follicular Lymphoma;Refractory Follicular Lymphoma
• United States
• 2017-08-30

• Recruiting

• Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer
• Anatomic Stage I Breast Cancer AJCC v8;Anatomic Stage IA Breast Cancer AJCC v8;Anatomic Stage IB Breast Cancer AJCC v8;Anatomic Stage II Breast Cancer AJCC v8;Anatomic Stage IIA Breast Cancer AJCC v8;Anatomic Stage IIB Breast Cancer AJCC v8;Anatomic Stage III Breast Cancer AJCC v8;Anatomic Stage IIIA Breast Cancer AJCC v8;Anatomic Stage IIIB Breast Cancer AJCC v8;Anatomic Stage IIIC Breast Cancer AJCC v8;Grade 1 Peripheral Motor Neuropathy, CTCAE;Grade 1 Peripheral Sensory Neuropathy, CTCAE;Grade 2 Peripheral Motor Neuropathy, CTCAE;Grade 2 Peripheral Sensory Neuropathy, CTCAE;Prognostic Stage I Breast Cancer AJCC v8;Prognostic Stage IA Breast Cancer AJCC v8;Prognostic Stage IB Breast Cancer AJCC v8;Prognostic Stage II Breast Cancer AJCC v8;Prognostic Stage IIA Breast Cancer AJCC v8;Prognostic Stage IIB Breast Cancer AJCC v8;Prognostic Stage III Breast Cancer AJCC v8;Prognostic Stage IIIA Breast Cancer AJCC v8;Prognostic Stage IIIB Breast Cancer AJCC v8;Prognostic Stage IIIC Breast Cancer AJCC v8;Anatomic Stage I Breast Cancer AJCC v8;Anatomic Stage IA Breast Cancer AJCC v8;Anatomic Stage IB Breast Cancer AJCC v8;Anatomic Stage II Breast Cancer AJCC v8;Anatomic Stage IIA Breast Cancer AJCC v8;Anatomic Stage IIB Breast Cancer AJCC v8;Anatomic Stage III Breast Cancer AJCC v8;Anatomic Stage IIIA Breast Cancer AJCC v8;Anatomic Stage IIIB Breast Cancer AJCC v8;Anatomic Stage IIIC Breast Cancer AJCC v8;Grade 1 Peripheral Motor Neuropathy, CTCAE;Grade 1 Peripheral Sensory Neuropathy, CTCAE;Grade 2 Peripheral Motor Neuropathy, CTCAE;Grade 2 Peripheral Sensory Neuropathy, CTCAE;Prognostic Stage I Breast Cancer AJCC v8;Prognostic Stage IA Breast Cancer AJCC v8;Prognostic Stage IB Breast Cancer AJCC v8;Prognostic Stage II Breast Cancer AJCC v8;Prognostic Stage IIA Breast Cancer AJCC v8;Prognostic Stage IIB Breast Cancer AJCC v8;Prognostic Stage III Breast Cancer AJCC v8;Prognostic Stage IIIA Breast Cancer AJCC v8;Prognostic Stage IIIB Breast Cancer AJCC v8;Prognostic Stage IIIC Breast Cancer AJCC v8
• United States
• 2018-04-12

• Recruiting

• Cabozantinib S-Malate, Crizotinib, Savolitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
• Stage III Renal Cell Cancer AJCC v7;Stage IV Renal Cell Cancer AJCC v7;Type 1 Papillary Renal Cell Carcinoma;Type 2 Papillary Renal Cell Carcinoma;Unresectable Renal Cell Carcinoma
• Canada, United States
• 2016-05-02

• Recruiting

• Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
• Waldenstrom Macroglobulinemia;Chronic Lymphocytic Leukemia;Hodgkin Disease;NonHodgkin Lymphoma;Mixed Lymphoproliferative Disease
• United States
• 2002-06-06

• Recruiting

• Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
• Lymphoma;Childhood Lymphoma;Solid Tumor;Childhood Solid Tumor;Neuroblastoma;Ewing Sarcoma;Hodgkin Lymphoma;Non-Hodgkin Lymphoma;Rhabdomyosarcoma;Soft Tissue Sarcoma;Medulloblastoma;Germ Cell Tumor;Wilms Tumor;Brain Neoplasms;Medulloblastoma, Childhood;Neuroectodermal Tumors, Primitive;Lymphoma;Childhood Lymphoma;Solid Tumor;Childhood Solid Tumor;Neuroblastoma;Ewing Sarcoma;Hodgkin Lymphoma;Non-Hodgkin Lymphoma;Rhabdomyosarcoma;Soft Tissue Sarcoma;Medulloblastoma;Germ Cell Tumor;Wilms Tumor;Brain Neoplasms;Medulloblastoma, Childhood;Neuroectodermal Tumors, Primitive;Lymphoma;Childhood Lymphoma;Solid Tumor;Childhood Solid Tumor;Neuroblastoma;Ewing Sarcoma;Hodgkin Lymphoma;Non-Hodgkin Lymphoma;Rhabdomyosarcoma;Soft Tissue Sarcoma;Medulloblastoma;Germ Cell Tumor;Wilms Tumor;Brain Neoplasms;Medulloblastoma, Childhood;Neuroectodermal Tumors, Primitive;Lymphoma;Childhood Lymphoma;Solid Tumor;Childhood Solid Tumor;Neuroblastoma;Ewing Sarcoma;Hodgkin Lymphoma;Non-Hodgkin Lymphoma;Rhabdomyosarcoma;Soft Tissue Sarcoma;Medulloblastoma;Germ Cell Tumor;Wilms Tumor;Brain Neoplasms;Medulloblastoma, Childhood;Neuroectodermal Tumors, Primitive
• United States
• 2015-10-27

• Recruiting

• A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
• Lymphoma, Non-Hodgkin;Lymphoma;Lymphoma, B-Cell;Lymphoma, Large B-Cell, Diffuse;Neoplasms;Neoplasms by Histologic Type;Lymphoproliferative Disorders;Lymphatic Diseases;Immunoproliferative Disorders;Immune System Disorder
• United States
• 2018-11-07

• Recruiting

• MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
• Mucopolysaccharidosis Disorders;Hurler Syndrome;Hunter Syndrome;Maroteaux Lamy Syndrome;Sly Syndrome;Alpha-Mannosidosis;Fucosidosis;Aspartylglucosaminuria;Glycoprotein Metabolic Disorders;Sphingolipidoses;Recessive Leukodystrophies;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy;Niemann-Pick B;Niemann-Pick C Subtype 2;Sphingomyelin Deficiency;Peroxisomal Disorders;Adrenoleukodystrophy With Cerebral Involvement;Zellweger Syndrome;Neonatal Adrenoleukodystrophy;Infantile Refsum Disease;Acyl-CoA Oxidase Deficiency;D-Bifunctional Enzyme Deficiency;Multifunctional Enzyme Deficiency;Alpha-methylacyl-CoA Racmase Deficiency;Mitochondrial Neurogastrointestingal Encephalopathy;Severe Osteopetrosis;Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation);Inherited Metabolic Disorders
• United States
• 2014-06-20